BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31276296)

  • 21. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
    Widmann G; Schullian P; Haidu M; Bale R
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical ablation of hepatocellular carcinoma with 2.45-GHz microwave: a critical appraisal of treatment outcomes.
    Lee KF; Hui JW; Cheung YS; Wong JS; Chong CN; Wong J; Yu SC; Lai PB
    Hong Kong Med J; 2012 Apr; 18(2):85-91. PubMed ID: 22477730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT-guided percutaneous microwave ablation of liver metastases from nasopharyngeal carcinoma.
    Li X; Fan WJ; Zhang L; Zhang XP; Jiang H; Zhang JL; Zhang H
    J Vasc Interv Radiol; 2013 May; 24(5):680-4. PubMed ID: 23622039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image-guided radiofrequency ablation of liver malignancies: experience at Singapore General Hospital.
    Low SC; Lo RH; Lau TN; Ooi LL; Ho CK; Tan BS; Chung AY; Koo WH; Chow PK
    Ann Acad Med Singap; 2006 Dec; 35(12):851-7. PubMed ID: 17218995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound-guided percutaneous microwave ablation vs. surgical resection for thoracoabdominal wall implants from hepatocellular carcinoma: intermediate-term results.
    An C; Hu ZL; Liang P; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2018 Nov; 34(7):1067-1076. PubMed ID: 29161924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation of subcapsular hepatocellular carcinoma: single center experience.
    Filippousis P; Sotiropoulou E; Manataki A; Konstantinopoulos O; Thanos L
    Eur J Radiol; 2011 Feb; 77(2):299-304. PubMed ID: 19733023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactically navigated percutaneous microwave ablation (MWA) compared to conventional MWA: a matched pair analysis.
    Beyer LP; Lürken L; Verloh N; Haimerl M; Michalik K; Schaible J; Stroszczynski C; Wiggermann P
    Int J Comput Assist Radiol Surg; 2018 Dec; 13(12):1991-1997. PubMed ID: 29728899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes.
    Xu Y; Shen Q; Liu P; Xu Z; Wu P; Lu Z; Chen Y; Huang B; Qian G
    Eur Radiol; 2017 Sep; 27(9):3877-3887. PubMed ID: 28188425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound.
    Liu F; Yu X; Liang P; Cheng Z; Han Z; Dong B
    Int J Hyperthermia; 2011; 27(6):555-62. PubMed ID: 21797695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
    Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
    [No Abstract]   [Full Text] [Related]  

  • 31. Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter.
    Calandri M; Ruggeri V; Carucci P; Mirabella S; Veltri A; Fonio P; Gazzera C
    Radiol Med; 2019 Oct; 124(10):1043-1048. PubMed ID: 31270723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robot-assisted microwave thermoablation of liver tumors: a single-center experience.
    Beyer LP; Pregler B; Niessen C; Dollinger M; Graf BM; Müller M; Schlitt HJ; Stroszczynski C; Wiggermann P
    Int J Comput Assist Radiol Surg; 2016 Feb; 11(2):253-9. PubMed ID: 26307269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study.
    Francica G; Meloni MF; Riccardi L; de Sio I; Terracciano F; Caturelli E; Iadevaia MD; Amoruso A; Roselli P; Chiang J; Scaglione M; Pompili M
    Eur J Radiol; 2018 Aug; 105():96-101. PubMed ID: 30017305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. US-guided percutanous microwave ablation for early-stage hepatocellular carcinoma in elderly patients is as effective as in younger patients: A 10-year experience.
    Wang Y; Cheng Z; Yu J; Li X; Hao G; Liu F; Han Z; Yu X; Liang P
    J Cancer Res Ther; 2020; 16(2):292-300. PubMed ID: 32474516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery.
    Shiina S; Sato K; Tateishi R; Shimizu M; Ohama H; Hatanaka T; Takawa M; Nagamatsu H; Imai Y
    Can J Gastroenterol Hepatol; 2018; 2018():4756147. PubMed ID: 29974040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients.
    Dong B; Liang P; Yu X; Su L; Yu D; Cheng Z; Zhang J
    AJR Am J Roentgenol; 2003 Jun; 180(6):1547-55. PubMed ID: 12760916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actual 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma: A Single-Center Experience in Japan.
    Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
    Ann Surg Oncol; 2019 Nov; 26(12):4126-4133. PubMed ID: 31359277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial institutional experience of uncooled single-antenna microwave ablation for large hepatocellular carcinoma.
    Liang PC; Lai HS; Shih TT; Wu CH; Huang KW
    Clin Radiol; 2015 May; 70(5):e35-40. PubMed ID: 25727299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
    PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous US-guided MWA of small liver HCC: predictors of outcome and risk factors for complications from a single center experience.
    Biondetti P; Fumarola EM; Ierardi AM; Coppola A; Gorga G; Maggi L; Valconi E; Angileri SA; Carrafiello G
    Med Oncol; 2020 Apr; 37(5):39. PubMed ID: 32239295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.